Your session is about to expire
← Back to Search
Behavioral Intervention
Mantram repetition program for Substance Use Disorder
N/A
Waitlist Available
Led By Ahmed Hassan, MD, MPH
Research Sponsored by Centre for Addiction and Mental Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; week 4; week 8; week 12 follow up. scale title: 12-item short form health survey , minimum value: 0 , maximum value : 100. the higher the score the better the outcome.
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a virtual program where adults with PTSD and substance use issues repeat a meaningful word or phrase to help reduce stress. The goal is to see if this practice can help them manage their symptoms better.
Eligible Conditions
- Substance Use Disorder
- Post-Traumatic Stress Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; week 4; week 8; week 12 follow up. scale title: 12-item short form health survey , minimum value: 0 , maximum value : 100. the higher the score the better the outcome.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; week 4; week 8; week 12 follow up. scale title: 12-item short form health survey , minimum value: 0 , maximum value : 100. the higher the score the better the outcome.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Rate of retention in the group
Secondary study objectives
Alcohol consumption
CAPS-5 PTSD Symptom Severity (past month)
Drug consumption
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Mantram repetition programExperimental Treatment1 Intervention
Weekly 90 minute virtual group therapy sessions for 8 weeks run by two faciliators and will consist of 5-8 participants.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mantram repetition program
2021
N/A
~80
Find a Location
Who is running the clinical trial?
Centre for Addiction and Mental HealthLead Sponsor
371 Previous Clinical Trials
83,211 Total Patients Enrolled
Ahmed Hassan, MD, MPHPrincipal InvestigatorCentre for Addiction and Mental Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- People who are 18 years old or older can participate in this study.The person was diagnosed with a substance use disorder other than tobacco or caffeine by a healthcare practitioner, confirmed by a Structured Clinical Interview for DSM-5.agreed not to participate in any other therapies during the program.You have been diagnosed with schizophrenia, schizoaffective disorder, or bipolar disorder, or are currently experiencing acute psychosis or mania according to a healthcare provider.You are at risk of committing suicide as determined by the Columbia Suicide Severity Rating Scale (C-SSRS).
Research Study Groups:
This trial has the following groups:- Group 1: Mantram repetition program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Learn More About These Treatments
Share this study with friends
Copy Link
Messenger